FULC - Fulcrum Therapeutics Inc
IEX Last Trade
8.55
-0.190 -2.222%
Share volume: 493,652
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$8.74
-0.19
-2.17%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-03-09 | 2023-05-15 | 2023-08-03 | 2023-11-07 | 2024-02-27 | 2024-05-13 | 2024-07-31 | |
| Total revenue | 1.183 M | 685.000 K | 295.000 K | 880.000 K | 759.000 K | 871.000 K | 0.000 | 80.000 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.183 M | 685.000 K | 295.000 K | 880.000 K | 759.000 K | 871.000 K | 0.000 | 80.000 M | |
| -42.10% | -56.93% | 198.31% | -13.75% | 14.76% | -100.00% | inf% | |||
| Operating expenses | 25.073 M | 28.696 M | 28.235 M | 28.172 M | 28.199 M | 28.863 M | 29.834 M | 27.508 M | |
| Selling general and admin | 9.707 M | 10.130 M | 11.520 M | 10.323 M | 9.961 M | 9.864 M | 10.061 M | 10.247 M | |
| Research and development | 15.366 M | 18.566 M | 16.715 M | 17.849 M | 18.238 M | 18.999 M | 19.773 M | 17.261 M | |
| Total expenses | 25.073 M | 28.696 M | 28.235 M | 28.172 M | 28.199 M | 28.863 M | 29.834 M | 27.508 M | |
| 14.45% | -1.61% | -0.22% | 0.10% | 2.35% | 3.36% | -7.80% | |||
| Operating income | -23.890 M | -28.011 M | -27.940 M | -27.292 M | -27.440 M | -27.992 M | -29.834 M | 52.492 M | |
| Ebit | -23.890 M | -28.011 M | -27.940 M | -27.292 M | -27.440 M | -27.992 M | -29.834 M | 52.492 M | |
| Pretax income | -23.738 M | -26.135 M | -24.779 M | -23.783 M | -24.017 M | -24.756 M | -26.870 M | 55.409 M | |
| 10.10% | -5.19% | -4.02% | 0.98% | 3.08% | 8.54% | -306.21% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -23.738 M | -26.135 M | -24.779 M | -23.783 M | -24.017 M | -24.756 M | -26.870 M | 55.409 M | |
| -10.10% | 5.19% | 4.02% | -0.98% | -3.08% | -8.54% | 306.21% | |||
| Net income | -23.738 M | -26.135 M | -24.779 M | -23.783 M | -24.017 M | -24.756 M | -26.870 M | 55.409 M | |
| -10.10% | 5.19% | 4.02% | -0.98% | -3.08% | -8.54% | 306.21% |